These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14739181)

  • 1. Whistleblower vows to fight on.
    Dyer C
    BMJ; 2004 Jan; 328(7433):187. PubMed ID: 14739181
    [No Abstract]   [Full Text] [Related]  

  • 2. Independent review adds to controversy at Sick Kids.
    Shuchman M
    CMAJ; 1999 Feb; 160(3):386-8. PubMed ID: 10065085
    [No Abstract]   [Full Text] [Related]  

  • 3. Olivieri to testify against Apotex in Europe.
    Bonetta L
    Nat Med; 2001 Jun; 7(6):644. PubMed ID: 11385480
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry and the academy: conflicts of interest in contemporary health research.
    Downie J; Baird P; Thompson J
    Health Law J; 2002; 10():103-22. PubMed ID: 14748274
    [No Abstract]   [Full Text] [Related]  

  • 5. Academia and industry: lessons from the unfortunate events in Toronto.
    Nathan DG; Weatherall DJ
    Lancet; 1999 Mar; 353(9155):771-2. PubMed ID: 10459956
    [No Abstract]   [Full Text] [Related]  

  • 6. Canadian whistleblower row prompts broader code of conduct.
    Spurgeon D
    Nature; 1998 Dec 24-31; 396(6713):715. PubMed ID: 9874365
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversial HSC clinical trials report made public. Hospital for Sick Children.
    Birmingham K
    Nat Med; 1999 Jan; 5(1):7. PubMed ID: 9883822
    [No Abstract]   [Full Text] [Related]  

  • 8. The report of the committee of inquiry on the case involving Dr. Nancy Olivieri: a fiduciary law perspective.
    Litman M; Sheremeta L
    Health Law Rev; 2002; 10(2):3-13. PubMed ID: 15739307
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA panel recommends approval of deferiprone.
    Shuchman M
    CMAJ; 2011 Nov; 183(16):E1159-60. PubMed ID: 21948726
    [No Abstract]   [Full Text] [Related]  

  • 10. An oral treatment for iron overload in thalassemia?
    Kowdley KV; Tavill AS
    Hepatology; 1996 Feb; 23(2):380-2. PubMed ID: 8591869
    [No Abstract]   [Full Text] [Related]  

  • 11. Academic freedom in clinical research.
    Nathan DG; Weatherall DJ
    N Engl J Med; 2002 Oct; 347(17):1368-71. PubMed ID: 12397199
    [No Abstract]   [Full Text] [Related]  

  • 12. The Olivieri Report--a compelling study of the growing tensions in clinical research.
    di Norcia V
    Sci Eng Ethics; 2003 Jan; 9(1):125-32. PubMed ID: 12645235
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical research: a tale of two studies.
    Nathan DG
    Trans Am Clin Climatol Assoc; 2003; 114():219-30; discussion 230-2. PubMed ID: 12813922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 15. Combining two orally active iron chelators for thalassemia.
    Berdoukas V; Carson S; Nord A; Dongelyan A; Gavin S; Hofstra TC; Wood JC; Coates T
    Ann Hematol; 2010 Nov; 89(11):1177-8. PubMed ID: 20217085
    [No Abstract]   [Full Text] [Related]  

  • 16. In the wake of the Mediator scandal: some progress in France, but apathy at the European level.
    Prescrire Int; 2012 Apr; 21(126):110. PubMed ID: 22515143
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox.
    Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):1-15. PubMed ID: 18274978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informed by the European Union experience: what the United States can anticipate and learn from the European Union's regulatory approach to biosimilars.
    Gitter DM
    Seton Hall Law Rev; 2011; 41(2):559-92. PubMed ID: 21739759
    [No Abstract]   [Full Text] [Related]  

  • 19. Second HSC researcher sends anonymous 'Olivieri' note. Hospital for Sick Children.
    Birmingham K
    Nat Med; 2000 May; 6(5):485. PubMed ID: 10802680
    [No Abstract]   [Full Text] [Related]  

  • 20. European Commission wants drug companies to test products for use in children.
    Watson R
    BMJ; 2004 Oct; 329(7470):818. PubMed ID: 15472249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.